Stock 600196 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Equities

600196

CNE000000X38

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
23.71 CNY +2.24% Intraday chart for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. +4.27% -5.27%
04-29 Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator MT

Evolution of the average Target Price on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

861987924e6e93d09890e801e06e9e06.XxXRhw78CgBCDHuFAMfqntfFNnXGO0UkPOo1_p5xrTY.EmaezD2jOnYhaiTqb6OZ-YKLY0SjCzdlZdNPjsobgH8mJ6bWdrInVwBjGA~9f4816ff7dfb2ae05a39af4f2b3ba7ff

Analyst Recommendations on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical : Fosun Pharma’s MSCI ESG Rating Upgraded to A PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.71 CNY
Average target price
29.75 CNY
Spread / Average Target
+25.47%
High Price Target
35 CNY
Spread / Highest target
+47.62%
Low Price Target
24.5 CNY
Spread / Lowest Target
+3.33%

Consensus detail

Consensus revision (last 18 months)

Ratings for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 600196 Stock
  4. Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd.